Barclays 28th Annual Global Healthcare Conference
Logotype for Tenet Healthcare Corporation

Tenet Healthcare (THC) Barclays 28th Annual Global Healthcare Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for Tenet Healthcare Corporation

Barclays 28th Annual Global Healthcare Conference summary

10 Mar, 2026

Strategic growth and operational focus

  • Maintains strong demand for high-acuity care in both ambulatory and acute hospital segments, supporting continued organic growth projections for 2024 and beyond.

  • Recent years included portfolio reorganization, asset divestitures, and targeted capital investments in retained markets, with expected returns from these initiatives.

  • Plans for 2026 include broad cost structure review and cost reduction initiatives, leveraging both AI and operational efficiencies.

  • Confident in guidance for 2026, citing robust market positions and ongoing strategic investments.

Technology and efficiency initiatives

  • AI and automation are central to future cost savings, enabling workforce efficiency and improved asset utilization, especially in ambulatory surgery.

  • Rightsizing overhead and operational improvements have already contributed to cost savings, with further gains expected from technology deployment.

  • Technology pilots aim to enhance asset utilization and productivity in both hospital and ambulatory segments.

Market dynamics and payer environment

  • ACA exchange headwinds are projected, with a 20% enrollment reduction and state-level variability impacting hospital segment guidance.

  • Some patients are expected to transition to other coverage types, partially offsetting volume declines.

  • Commercial rates are tracking 3%-5% with strong visibility through 2027, supported by value-driven negotiations and disciplined utilization.

  • Employment trends remain strong, with no significant impact on payer mix or utilization observed.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more